Showing results (171-180 of 271) with videos related to

Sort By:
Pageof 28
The Journal of Allergy and Clinical Immunology|August 13, 2021
Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitutionOttavia M Delmonte, Riccardo Castagnoli, Jason Yu, et al.
Medcomm|August 15, 2024
Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseasesJia-Chen Liu, Ke Zhang, Xu Zhang, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2013
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 yearsAntonia Kwan, Joseph A Church, Morton J Cowan, et al.
The Journal of Allergy and Clinical Immunology|April 30, 2013
Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicismAmy P Hsu, Kathryn J Sowerwine, Monica G Lawrence, et al.
Immunity|August 1, 2025
Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1Anoop Babu Vasandan, Hossam A Abdelsamed, Shannon K Boi, et al.
The Journal of Allergy and Clinical Immunology|December 3, 2013
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experienceWilliam T Shearer, Elizabeth Dunn, Luigi D Notarangelo, et al.
Nature Immunology|October 7, 2008
The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiencyLawrence R Shiow, David W Roadcap, Kenneth Paris, et al.
Human Gene Therapy|September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined ImmunodeficiencyDivya Punwani, Misako Kawahara, Jason Yu, et al.
American Journal of Medical Genetics. Part A|August 20, 2015
NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retinaNuria Garcia Segarra, Diana Ballhausen, Heather Crawford, et al.
Eclinicalmedicine|December 9, 2024
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)Yves Levy, Christiane Moog, Aurélie Wiedemann, et al.
Pageof 28